Beluga Biozymes Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-12-2024
- Paid Up Capital ₹ 2.20 M
as on 29-12-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 4.19 Cr
as on 29-12-2024
- Revenue -61.54%
(FY 2019)
- Profit 70.39%
(FY 2019)
- Ebitda 14.20%
(FY 2019)
- Net Worth -1.19%
(FY 2019)
- Total Assets -1.36%
(FY 2019)
About Beluga Biozymes
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M.
The company has closed loans amounting to ₹4.19 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhiren Khot, Madhushri Khot, and Rishabh Khot serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PTC134971
- Company No.
134971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2002
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Beluga Biozymes?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhiren Khot  | Whole-Time Director | 21-Feb-2002 | Current |
| Madhushri Khot | Director | 01-Apr-2010 | Current |
| Rishabh Khot | Director | 01-Apr-2010 | Current |
Financial Performance of Beluga Biozymes.
Beluga Biozymes Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 61.54% decrease. The company also saw a substantial improvement in profitability, with a 70.39% increase in profit. The company's net worth dipped by a decrease of 1.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Beluga Biozymes?
In 2019, Beluga Biozymes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lexicon Chemicals Private LimitedActive 32 years 8 monthsDhiren Khot, Madhushri Khot and 1 more are mutual person
Beluga Chemicals Private LimitedActive 28 years 7 monthsDhiren Khot, Madhushri Khot and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The North Kanara G. S. B. Co-Op. Bank Ltd. Creation Date: 02 Jan 2007 | ₹7.50 M | Satisfied |
The North Kanara G. S. B. Co-Op. Bank Ltd. Creation Date: 12 Oct 2006 | ₹2.00 Cr | Satisfied |
The North Kanara G. S. B. Co-Op. Bank Ltd. Creation Date: 12 Oct 2006 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Beluga Biozymes?
Unlock and access historical data on people associated with Beluga Biozymes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beluga Biozymes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beluga Biozymes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
